Ingemar Turesson
91 – 100 of 123
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Immune-Related and Inflammatory Conditions Likely Play a Role in the Development of Lymphoplasmacytic Lymphoma/Waidenstrom's Macroglobulinemia.
(
- Contribution to journal › Published meeting abstract
-
Mark
Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group
(
- Contribution to journal › Article
-
Mark
Germline Genes Specific to Chronic Lymphocytic Leukemia (CLL) and Genes Common to CLL, Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinemia, and Other Non-Hodgkin Lymphomas Are Important in Susceptibility
(
- Contribution to journal › Published meeting abstract
-
Mark
Familial characteristics of Waldenström's macroglobulinemia (WM) and lymphoplasmacytic lymphoma (LPL): A population-based study in Sweden
2008) 10th International Conference on Malignant Lymphoma In Annals of Oncology 19(Suppl. 4). p.166-166(
- Contribution to journal › Published meeting abstract
-
Mark
A Randomised Placebo Controlled Study With Melphalan/Prednisone Vs Melphalan/Prednisone/Thalidomide: Quality Of Life And Toxicity
2008) 13th Congress of the European-Hematology-Association In Haematologica-The Hematology Journal 93. p.0209-0209(
- Contribution to journal › Published meeting abstract
- 2007
-
Mark
An internadional field study of the reliability and validity of a disease-specfic questionnanire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma
(
- Contribution to journal › Article
-
Mark
Risk of malignant disease among 1525 adult male US veterans with gaucher disease
(
- Contribution to journal › Article
-
Mark
Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003.
(
- Contribution to journal › Article
- 2006
-
Mark
Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States
(
- Contribution to journal › Article
-
Mark
Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation
(
- Contribution to journal › Article